Stem Cell Therapy Shows Promise in First Human Parkinson’s Disease Trial
One year findings from Phase I/II clinical study support the feasibility of transplanting stem-cell derived dopamine progenitor cells into the brain of Parkinson’s disease patients. The post Stem…
Read the full articleYou might also wanna read
Macrophage Membrane-Derived Nanoparticles Shows Potential Against Candida Infections
GEN·9h ago
Quantum Computing Applied to Protein–Ligand Binding Energy Calculations for Drug Discovery
pubs.acs.org·15h ago
Top 10 Best-Selling Drugs 2026
GEN·1d ago
Novartis Postdoctoral Fellowship: Machine Learning for Chemical Synthesis and Reactivity Prediction
novartis.com·7d ago
Anthropic Launches Claude Science Platform, Entering AI Drug Discovery Race Against DeepMind and OpenAI
awesomeagents.ai·8d ago
Deep-learning platform GPS enables de novo drug discovery by predicting transcriptomic perturbations from chemical structures
cell.com·10d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.